CompletedNCT01110694

Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Principal Investigator
Toby M Maher, MB PhD
Royal Brompton and Harefield Foundation NHS Trust
Enrollment
230 enrolled
Eligibility
18 years · All sexes
Timeline
2010 – 2018

Study locations (1)

Collaborators

GlaxoSmithKline · University College, London · University of Nottingham

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01110694 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials